Kathleen Griffith
Kathleen Griffith
Ph.D., M.P.H., FNP-BC, FAAN
Associate Dean, Research
Professor (Tenured)
Department: Research Administration
Contact:
Email:
Kathleen Griffith
Office Phone:
202-994-0025
1919 Pennsylvania Avenue, NW, Suite 500, 517
Washington DC 20006
Kathleen Griffith, professor (tenured), focuses on symptom management related to cancer and its treatment. Her program of research addresses symptom management using non-pharmacologic interventions for cancer and other chronic illnesses, and management of chemotherapy-induced peripheral neuropathy. She has received funding from the National Institutes of Health, the American Cancer Society, and the Oncology Nursing Society.
- Johns Hopkins University School of Nursing – Post-Doctoral training
- University of Maryland –Doctor of Philosophy in Nursing
- University of Maryland – Master of Public Health
- Georgetown University – Master of Science in Nursing
- Georgetown University – Bachelor of Science in Nursing
- Griffith KA, Zhu S, Chung SY, and Ryan AS (2016). Insulin resistance and inflammation in Black women with and without breast cancer: cause for concern. Ethnicity and Disease. 23(4):513-20. PMCID: PMC5072480
- Chung SY, Zhu S, Friedmann E, Kelleher C, Kozlovsky A, Macfarlane KW, Tkaczuk KHR, Ryan AS, & Griffith KA (2016). Weight loss with mindful eating in African American women following treatment for breast cancer: a longitudinal study. Journal of Supportive Care in Cancer. 24(4):1875-81. PMCID: PMC4909150
- Griffith KA, Couture D.J., Zhu, S., Pandya, N., Johantgen, M.E., Cavaletti, G., Davenport, J.M.,Tanguay, L.J., Choflet, A., Milliron, T., Glass, E., Gambill, N., Renn, C.L, Dorsey, S.G. (2014). Evaluation of chemotherapy-induced peripheral neuropathy using current perception threshold and clinical evaluations. Journal of Supportive Care in Cancer, 22(5):1161-9. PMID: 24362842.
- Griffith KA, Dorsey SG, Renn CL, Zhu S, Johantgen ME, Cornblath DR, Argyriou AA, Cavaletti G, MD, Merkies ISJ, Alberti P, Postma TJ, Rossi E, Frigeni F, Bruna J, Velasco R, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galie E, Briani C, Dalla Torre C, Faber CG, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey DJ, Kerrigan S, Schenone A, Fabbri S, Valsecchi MG, and the **CI-PeriNomS Group (2014). Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNoms study. Journal of the Peripheral Nervous System, 19(2):127-35. PMID: 24814100
- Weight gain during cancer treatment
- Chemotherapy-induced peripheral neuropathy measurement and management
- Physical activity and dietary intervention trials
- Oncology
- Rehabilitation
- Veteran / Military Health